신경혈관 디바이스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 디바이스별, 치료 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Neurovascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By Therapeutic Application, By End User, By Region and Competition, 2020-2030F
상품코드:1748735
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 신경혈관 디바이스 시장 규모는 2024년에 74억 8,000만 달러, 2030년에는 105억 2,000만 달러에 달하며, CAGR 5.82%로 성장할 것으로 예측됩니다.
이 시장은 뇌졸중, 동맥류, 동정맥 기형과 같은 신경혈관 질환의 유병률 증가로 인해 빠르게 성장하고 있습니다. 의료 시스템이 조기 개입을 우선시하는 가운데, 신속하고 최소 침습적인 치료를 가능하게 하는 첨단 신경혈관 기술에 대한 요구가 증가하고 있습니다. 영상 진단, 카테터 시스템, 스텐트 회수 방법의 기술 발전은 환자 예후와 시술 효율을 크게 향상시키고 있습니다. 의료 전문가와 환자들 사이에서 최소침습적 시술의 장점에 대한 인식이 높아진 것도 시술의 광범위한 채택에 기여하고 있습니다. 또한 신경질환에 취약한 노인 인구 증가는 조기 회복을 촉진하고 수술 위험을 줄여주는 신경혈관 전문 솔루션에 대한 수요를 더욱 증가시키고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
74억 8,000만 달러
시장 규모 : 2030년
105억 2,000만 달러
CAGR : 2025-2030년
5.82%
급성장 부문
뇌동맥류
최대 시장
북미
시장 성장 촉진요인
뇌졸중 및 신경혈관질환 발생률 증가
주요 시장 이슈
높은 장비 및 시술 비용
주요 시장 동향
인공지능(AI) 및 이미지 유도 내비게이션 도입 확대
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 신경혈관 디바이스 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
디바이스별(뇌색전술 및 동맥류 코일 색전술 디바이스, 뇌혈관 성형술 및 스텐트 유치 시스템, 신경혈전제거 디바이스, 지원 디바이스, 경요골동맥 액세스 디바이스)
치료 용도별(뇌졸중, 뇌동맥, 뇌동맥류, 기타)
최종사용자별(병원, 전문 클리닉, 기타)
기업별(2024)
지역별
시장 맵
제6장 북미의 신경혈관 디바이스 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 신경혈관 디바이스 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 신경혈관 디바이스 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 신경혈관 디바이스 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 신경혈관 디바이스 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 혼란 : 분쟁, 팬데믹, 무역장벽
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Medtronic plc
Stryker Corporation
Terumo Corporation
Penumbra, Inc.
Johnson & Johnson Services, Inc.
Integra LifeSciences Corporation
Acandis GmbH
Spiegelberg GmbH & Co. KG
MicroPort Scientific Corporation
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.48 Billion
Market Size 2030
USD 10.52 Billion
CAGR 2025-2030
5.82%
Fastest Growing Segment
Cerebral Aneurysm
Largest Market
North America
Key Market Drivers
Rising Incidence of Stroke and Neurovascular Disorders
The increasing frequency of strokes and related neurovascular disorders is a major force behind the market's growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.
Key Market Challenges
High Cost of Devices and Procedures
The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.
Key Market Trends
Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation
A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies-such as MRI and CT angiography-not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.
Key Market Players
Medtronic plc
Stryker Corporation
Terumo Corporation
Penumbra, Inc.
Johnson & Johnson Services, Inc.
Integra LifeSciences Corporation
Acandis GmbH
Spiegelberg GmbH & Co. KG
MicroPort Scientific Corporation
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Report Scope
In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Neurovascular Devices Market, By Device:
Cerebral Embolization and Aneurysm Coiling Devices
Cerebral Angioplasty and Stenting Systems
Neurothrombectomy Devices
Support Devices
Trans Radial Access Devices
Neurovascular Devices Market, By Therapeutic Application:
Stroke
Cerebral Artery
Cerebral Aneurysm
Others
Neurovascular Devices Market, By End User:
Hospitals
Specialty Clinics
Others
Neurovascular Devices Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.
Available Customizations
Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Neurovascular Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
5.2.3. By End User (Hospitals, Specialty Clinics, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Neurovascular Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device
6.2.2. By Therapeutic Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Neurovascular Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Device
6.3.1.2.2. By Therapeutic Application
6.3.1.2.3. By End User
6.3.2. Mexico Neurovascular Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Device
6.3.2.2.2. By Therapeutic Application
6.3.2.2.3. By End User
6.3.3. Canada Neurovascular Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Device
6.3.3.2.2. By Therapeutic Application
6.3.3.2.3. By End User
7. Europe Neurovascular Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device
7.2.2. By Therapeutic Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Neurovascular Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Device
7.3.1.2.2. By Therapeutic Application
7.3.1.2.3. By End User
7.3.2. Germany Neurovascular Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Device
7.3.2.2.2. By Therapeutic Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Neurovascular Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Device
7.3.3.2.2. By Therapeutic Application
7.3.3.2.3. By End User
7.3.4. Italy Neurovascular Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Device
7.3.4.2.2. By Therapeutic Application
7.3.4.2.3. By End User
7.3.5. Spain Neurovascular Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Device
7.3.5.2.2. By Therapeutic Application
7.3.5.2.3. By End User
8. Asia-Pacific Neurovascular Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device
8.2.2. By Therapeutic Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Neurovascular Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Device
8.3.1.2.2. By Therapeutic Application
8.3.1.2.3. By End User
8.3.2. India Neurovascular Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Device
8.3.2.2.2. By Therapeutic Application
8.3.2.2.3. By End User
8.3.3. South Korea Neurovascular Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Device
8.3.3.2.2. By Therapeutic Application
8.3.3.2.3. By End User
8.3.4. Japan Neurovascular Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Device
8.3.4.2.2. By Therapeutic Application
8.3.4.2.3. By End User
8.3.5. Australia Neurovascular Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Device
8.3.5.2.2. By Therapeutic Application
8.3.5.2.3. By End User
9. South America Neurovascular Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device
9.2.2. By Therapeutic Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Neurovascular Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device
9.3.1.2.2. By Therapeutic Application
9.3.1.2.3. By End User
9.3.2. Argentina Neurovascular Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device
9.3.2.2.2. By Therapeutic Application
9.3.2.2.3. By End User
9.3.3. Colombia Neurovascular Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device
9.3.3.2.2. By Therapeutic Application
9.3.3.2.3. By End User
10. Middle East and Africa Neurovascular Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device
10.2.2. By Therapeutic Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Neurovascular Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device
10.3.1.2.2. By Therapeutic Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device
10.3.2.2.2. By Therapeutic Application
10.3.2.2.3. By End User
10.3.3. UAE Neurovascular Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device
10.3.3.2.2. By Therapeutic Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Medtronic plc
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Stryker Corporation
15.3. Terumo Corporation
15.4. Penumbra, Inc.
15.5. Johnson & Johnson Services, Inc.
15.6. Integra LifeSciences Corporation
15.7. Acandis GmbH
15.8. Spiegelberg GmbH & Co. KG
15.9. MicroPort Scientific Corporation
15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
